You are viewing: Japan Structural Heart Devices Market analysis

The Japan Structural Heart Devices Market was valued at $577.3 Million in 2024 and projected to reach to $977.6 Million by 2029, representing a compound annual growth rate of 11.1%. Japan's structural heart devices market is positioned for sustained growth through 2029, driven by demographic shifts and healthcare modernization.

Japan Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Structural Heart Devices Market Trends and Insights

  • This 11.1% compound annual growth rate reflects Japan's aging population, rising prevalence of cardiac conditions, and increasing adoption of minimally invasive interventional procedures.
  • Japan's advanced healthcare infrastructure and strong reimbursement policies are driving demand for innovative structural heart solutions including transcatheter aortic valve replacement (TAVR), left atrial appendage (LAA) closure devices, and mitral valve repair systems. The Japanese market benefits from a well-established medical device ecosystem and high patient awareness of structural heart treatment options.
  • Japan's regulatory environment, supported by the Pharmaceuticals and Medical Devices Agency (PMDA), facilitates timely market access for breakthrough technologies.
  • Between 2024 and 2029, Japan is expected to see accelerated adoption driven by an expanding elderly demographic, improved clinical evidence, and growing physician expertise in structural heart interventions..

Key Market Statistics

  • CAGR (2024-2029) 11.1% CAGR
  • Market Size, 2024 ~USD 577.3 Million
  • Forecast, 2029 ~USD 977.6 Million
  • Country Japan

Japan Structural Heart Devices Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing the prevalence of structural heart diseases, creating sustained demand for innovative treatment solutions.

Minimally Invasive Procedure Adoption :

Japanese healthcare providers are increasingly adopting catheter-based and transcatheter interventions, reducing patient recovery times and hospital stays, which aligns with Japan's preference for advanced, less invasive medical technologies.

Strong Healthcare Infrastructure :

Japan's world-class healthcare system, high medical device reimbursement rates, and regulatory efficiency enable rapid market penetration of cutting-edge structural heart devices and technologies.

Rising Cardiac Condition Prevalence :

Increasing incidence of atrial fibrillation, mitral valve disease, and aortic stenosis among Japan's aging population is propelling growth in structural heart device utilization and market expansion.

Japan Structural Heart Devices Market Dynamics

  • The 11.1% CAGR significantly outpaces the global average of 9.5%, reflecting Japan's unique combination of an aging population and advanced medical infrastructure.
  • Reimbursement policies and clinical adoption of transcatheter solutions will continue to accelerate market expansion. Key growth catalysts include increasing prevalence of valvular heart disease, expanding catheterization laboratory capacity, and growing patient awareness of minimally invasive options.
  • Strategic partnerships between international device manufacturers and Japanese healthcare institutions will further enhance market penetration, positioning Japan as a critical growth market within the Asia-Pacific region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Japan's structural heart devices market will grow from USD 577.3 million in 2024 to USD 977.6 million by 2029, representing an 11.1% CAGR.
    • Japan's aging population and rising cardiac disease prevalence are primary drivers of structural heart device adoption across the forecast period.
    • Japan's advanced healthcare infrastructure and PMDA regulatory support enable rapid commercialization of innovative structural heart technologies.
    • Minimally invasive procedures including TAVR and LAA closure are gaining traction in Japan due to improved clinical outcomes and patient preference.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Japan Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    JAPAN: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS101.9111.8122.3133.8146.5160.5176.1193.49.6
    HOSPITALS726.4802.2883.1972.91072.11182.91306.21443.710.3
    OTHER END USERS (CATH LABS, CARDIAC CENTERS)91.2101.6112.9125.5139.6155.4173.2193.211.3
    TOTAL919.51015.71118.31232.31358.21498.81655.51830.210.4

    Target Audience

    • Medical Device Manufacturers : Strategic planning and market entry decisions require Japan-specific market sizing, competitive analysis, and regulatory intelligence to optimize product launches and capture market share in this high-growth segment.
    • Healthcare Investment Firms : Investment thesis development and portfolio company valuations depend on accurate Japan market data, growth projections, and sector dynamics to identify attractive opportunities in structural heart device companies.
    • Hospital & Healthcare Systems : Procurement and capital budgeting decisions require market intelligence on device innovations, pricing trends, and clinical outcomes specific to Japan's healthcare environment and patient demographics.
    • Market Research & Consulting Firms : Client deliverables and strategic recommendations require comprehensive Japan market analysis, including competitive positioning, regulatory landscape, and growth drivers to support consulting engagements.
    • Regulatory & Policy Advisors : Policy development and regulatory strategy require detailed understanding of Japan's unique market dynamics, reimbursement mechanisms, and healthcare infrastructure to inform evidence-based recommendations.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for Japan ($577.3M in 2024) with verified 11.1% CAGR projections through 2029, enabling accurate financial forecasting and investment decision-making specific to this high-growth market.
    • Competitive Landscape Intelligence : Understand Japan-specific competitive dynamics, market share distribution among device manufacturers, and strategic positioning opportunities within Asia's most advanced healthcare economy.
    • Regulatory & Reimbursement Insights : Access detailed analysis of Japan's unique regulatory pathways, reimbursement structures, and healthcare policies that directly impact device adoption rates and market entry strategies.
    • Demographic & Clinical Trends : Leverage Japan-specific epidemiological data on aging populations, cardiac disease prevalence, and procedural adoption rates to identify high-potential patient segments and clinical applications.
    • Strategic Market Entry Planning : Develop targeted go-to-market strategies with Japan-specific insights on healthcare provider preferences, distribution channels, and partnership opportunities to maximize market penetration and ROI.

    Frequently asked questions

    What is the current size of Japan's structural heart devices market?

    Japan's structural heart devices market was valued at USD 577.3 million in 2024 and is expected to grow to USD 977.6 million by 2029.

    What is the projected growth rate for Japan's structural heart devices market?

    Japan's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2029.

    What factors are driving growth in Japan's structural heart devices market?

    Key growth drivers in Japan include an aging population, rising prevalence of cardiac conditions, strong healthcare infrastructure, favorable reimbursement policies, and increasing adoption of minimally invasive procedures.

    Which structural heart devices are most commonly used in Japan?

    The most commonly used structural heart devices in Japan include transcatheter aortic valve replacement (TAVR) systems, left atrial appendage (LAA) closure devices, and mitral valve repair solutions.

    How does Japan's regulatory environment support structural heart device innovation?

    Japan's Pharmaceuticals and Medical Devices Agency (PMDA) provides a streamlined regulatory pathway that facilitates timely market access for breakthrough structural heart technologies.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status